Syndecan-1: a key player in health and disease
Authors:
- 17 December 2024
- journal article
- review article
- Published by Springer Nature in Immunogenetics
- Vol. 77 (1) , 1-19
Abstract
Syndecan-1 (SDC-1) is a transmembrane protein localized on the basolateral surface of epithelial cells, encompassing a core protein with heparin sulfate and chondroitin sulfate glycosaminoglycan side chains. SDC-1 is involved in a panoply of cellular mechanisms including cell-to-cell adhesion, extracellular matrix interactions, cell cycle modulation, and lipid clearance. Alterations in the expression and function of SDC-1 are implicated in numerous disease entities, making it an attractive diagnostic and therapeutic target. However, despite its broad involvement in several disease processes, the underlying mechanism contributing to its diverse functions, pathogenesis, and therapeutic uses remains underexplored. Therefore, this review examines the role of SDC-1 in health and disease, focusing on liver pathologies, inflammatory diseases, infectious diseases, and cancer, and sheds light on SDC-1-based therapeutic approaches. Moreover, it delves into the mechanisms through which SDC-1 contributes to these diseases, emphasizing cell-type specific mechanisms. By comprehensively summarizing the significance of SDC-1, its association with several diseases, and its underlying mechanisms of action, the findings of this review could inform future research directions toward the development of targeted therapies and early diagnosis for a multitude of disease entities.Keywords
This publication has 94 references indexed in Scilit:
- Lack of Syndecan-1 promotes the pathogenesis of experimental rheumatoid arthritisImmunogenetics, 2024
- Aberrant Expression of Syndecan-1 in Cervical CancersPathology and Oncology Research, 2020
- Syndecan‐1 limits the progression of liver injury and promotes liver repair in acetaminophen‐induced liver injury in miceHepatology, 2017
- Top‐down proteomics in health and disease: Challenges and opportunitiesProteomics, 2014
- Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma modelsBiochemical Pharmacology, 2013
- Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acidBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Shedding of Syndecan–1 From Human Hepatocytes Alters Very Low Density Lipoprotein ClearanceHepatology, 2011
- Inhibition of histone acetyltransferase by glycosaminoglycansJournal of Cellular Biochemistry, 2008
- Recombinant CBD–HepII polypeptide of fibronectin inhibits αvβ3 signaling and hematogenous metastasis of tumorBiochemical and Biophysical Research Communications, 2008
- Syndecan-1: a dynamic regulator of the myeloma microenvironmentClinical & Experimental Metastasis, 2007